BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37768341)

  • 1. Omentin-1 induces mechanically activated fibroblasts lipogenic differentiation through pkm2/yap/pparγ pathway to promote lung fibrosis resolution.
    Zhang Y; Fu J; Li C; Chang Y; Li X; Cheng H; Qiu Y; Shao M; Han Y; Feng D; Yue S; Sun Z; Luo Z; Zhou Y
    Cell Mol Life Sci; 2023 Sep; 80(10):308. PubMed ID: 37768341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis.
    Kheirollahi V; Wasnick RM; Biasin V; Vazquez-Armendariz AI; Chu X; Moiseenko A; Weiss A; Wilhelm J; Zhang JS; Kwapiszewska G; Herold S; Schermuly RT; Mari B; Li X; Seeger W; Günther A; Bellusci S; El Agha E
    Nat Commun; 2019 Jul; 10(1):2987. PubMed ID: 31278260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
    Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyruvate kinase M2 regulates fibrosis development and progression by controlling glycine auxotrophy in myofibroblasts.
    Satyanarayana G; Turaga RC; Sharma M; Wang S; Mishra F; Peng G; Deng X; Yang J; Liu ZR
    Theranostics; 2021; 11(19):9331-9341. PubMed ID: 34646373
    [No Abstract]   [Full Text] [Related]  

  • 5. Fructose-1,6-bisphosphate prevents pulmonary fibrosis by regulating extracellular matrix deposition and inducing phenotype reversal of lung myofibroblasts.
    Dias HB; de Oliveira JR; Donadio MVF; Kimura S
    PLoS One; 2019; 14(9):e0222202. PubMed ID: 31509566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Effects of Omentin-1 on Pulmonary Fibrosis by Attenuating Fibroblast Activation via AMP-Activated Protein Kinase Pathway.
    Zhou Y; Zhang Y; Cheng H; Li X; Feng D; Yue S; Xu J; Xie H; Luo Z
    Biomedicines; 2022 Oct; 10(11):. PubMed ID: 36359232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathways.
    Tumelty KE; Smith BD; Nugent MA; Layne MD
    J Biol Chem; 2014 Jan; 289(5):2526-36. PubMed ID: 24344132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the Reversible Myogenic to Lipogenic Transdifferentiation Switch for the Design of Pre-clinical Drug Screening in Idiopathic Pulmonary Fibrosis.
    Lingampally A; Jones MR; Bagari S; Chen C; Rivetti S; Bellusci S
    Front Bioeng Biotechnol; 2020; 8():569865. PubMed ID: 33042971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of RUNX1 blocks the differentiation of lung fibroblasts to myofibroblasts.
    Dubey S; Dubey PK; Umeshappa CS; Ghebre YT; Krishnamurthy P
    J Cell Physiol; 2022 Apr; 237(4):2169-2182. PubMed ID: 35048404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis.
    El Agha E; Moiseenko A; Kheirollahi V; De Langhe S; Crnkovic S; Kwapiszewska G; Szibor M; Kosanovic D; Schwind F; Schermuly RT; Henneke I; MacKenzie B; Quantius J; Herold S; Ntokou A; Ahlbrecht K; Braun T; Morty RE; Günther A; Seeger W; Bellusci S
    Cell Stem Cell; 2017 Feb; 20(2):261-273.e3. PubMed ID: 27867035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinamide N-methyltransferase mediates lipofibroblast-myofibroblast transition and apoptosis resistance.
    Rehan M; Deskin B; Kurundkar AR; Yadav S; Matsunaga Y; Manges J; Smith N; Dsouza KG; Burow ME; Thannickal VJ
    J Biol Chem; 2023 Aug; 299(8):105027. PubMed ID: 37423298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
    Cho N; Razipour SE; McCain ML
    Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production.
    Al-Habeeb F; Aloufi N; Traboulsi H; Liu X; Nair P; Haston C; Azuelos I; Huang SK; White ES; Gallouzi IE; Di Marco S; Eidelman DH; Baglole CJ
    J Cell Physiol; 2021 Oct; 236(10):6836-6851. PubMed ID: 33855709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eliglustat exerts anti-fibrotic effects by activating SREBP2 in TGF-β1-treated myofibroblasts derived from patients with idiopathic pulmonary fibrosis.
    Kurumiya E; Iwata M; Kasuya Y; Tatsumi K; Honda T; Murayama T; Nakamura H
    Eur J Pharmacol; 2024 Mar; 966():176366. PubMed ID: 38296153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis.
    Xie N; Tan Z; Banerjee S; Cui H; Ge J; Liu RM; Bernard K; Thannickal VJ; Liu G
    Am J Respir Crit Care Med; 2015 Dec; 192(12):1462-74. PubMed ID: 26284610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanosensor YAP cooperates with TGF-β1 signaling to promote myofibroblast activation and matrix stiffening in a 3D model of human cardiac fibrosis.
    Ragazzini S; Scocozza F; Bernava G; Auricchio F; Colombo GI; Barbuto M; Conti M; Pesce M; Garoffolo G
    Acta Biomater; 2022 Oct; 152():300-312. PubMed ID: 36055606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired Myofibroblast Dedifferentiation Contributes to Nonresolving Fibrosis in Aging.
    Kato K; Logsdon NJ; Shin YJ; Palumbo S; Knox A; Irish JD; Rounseville SP; Rummel SR; Mohamed M; Ahmad K; Trinh JM; Kurundkar D; Knox KS; Thannickal VJ; Hecker L
    Am J Respir Cell Mol Biol; 2020 May; 62(5):633-644. PubMed ID: 31962055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
    Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
    Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I collagen induces mesenchymal cell differentiation into myofibroblasts through YAP-induced TGF-β1 activation.
    Liu X; Long X; Liu W; Zhao Y; Hayashi T; Yamato M; Mizuno K; Fujisaki H; Hattori S; Tashiro SI; Ogura T; Atsuzawa Y; Ikejima T
    Biochimie; 2018 Jul; 150():110-130. PubMed ID: 29777737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice.
    Rahaman SO; Grove LM; Paruchuri S; Southern BD; Abraham S; Niese KA; Scheraga RG; Ghosh S; Thodeti CK; Zhang DX; Moran MM; Schilling WP; Tschumperlin DJ; Olman MA
    J Clin Invest; 2014 Dec; 124(12):5225-38. PubMed ID: 25365224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.